Call for local people aged over 60 to take part in new research
15 June 2023 - Anyone aged over 60, who has had a UTI in the last two years, is eligible to take part in a new research project
People aged 60 years and older will play a vital role in a new research study to assess the effectiveness and safety of an investigational vaccine in preventing bloodstream infections.
King’s College Hospital has opened a new clinical trial to assess the effectiveness and safety of an E.Coli vaccine in preventing bloodstream infection. People aged 60 years or older with a history of urinary tract infection (UTI) are at an increased risk of developing a bloodstream infection caused by E.coli bacteria.
Dr Nicholas Faure Walker, Consultant Urologist, who is leading the trial at King’s College Hospital, said, “This trial will assess whether an E.Coli vaccine can prevent serious infections in the over 60s and may also show whether the vaccine can prevent urinary tract infections. Anyone over 60 who has had a UTI in the last two years is eligible to take part.”
To be eligible to join the study, participants must have had a UTI in the past two years, be aged 60 or older and should feel comfortable, or have a caregiver who is comfortable using an application on a smartphone.
If you are interested, additional eligibility criteria will be assessed by the study doctor or staff.
If eligible to participate in this clinical research study, participants will receive an investigational vaccine and complete a minimum of eight study visits, some in person and some remote via telephone.
The commitment for the study is approximately 3 years. Qualified participants may receive the investigational vaccine and some study-required medical care at no cost.